Do you know how to get the J-START quality assurance guideline? Takayoshi UematsuSeigo NakamuraNoriaki Ohuchi Editorial 09 May 2018 Pages: 375 - 376
The long and winding road for overcoming resistance to hormone therapy in breast cancer Shigehira Saji Special Feature 28 May 2018 Pages: 377 - 378
Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications Toru HanamuraShin-ichi Hayashi Special Feature 07 April 2017 Pages: 379 - 391
Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer Kazuhiro ArakiYasuo Miyoshi Special Feature 31 October 2017 Pages: 392 - 401
Clinical development of CDK4/6 inhibitor for breast cancer Hiroji Iwata Special Feature 01 February 2018 Pages: 402 - 406
Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial N. MasudaM. ToiS. Ohno Original Article Open access 14 February 2018 Pages: 407 - 415
Clinical utility of RT-PCR in assessing HER 2 gene expression versus traditional IHC and FISH in breast cancer patients Moushumi SuryavanshiAnurag MehtaBhudev C. Das Original Article 09 February 2018 Pages: 416 - 430
Correlation of FANCM expression with clinical factors in luminal B breast cancer Yiran WangJunnan WangYajie Wang Original Article 31 January 2018 Pages: 431 - 437
Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY) Shoichiro OhtaniTakahiro NakayamaNorikazu Masuda Original Article Open access 12 February 2018 Pages: 438 - 446
OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer Jia-Ming ZhangKai WeiMing Jiang Original Article 13 March 2018 Pages: 447 - 455
Preoperative breast MRI: reproducibility and significance of findings relevant to nipple–areolar complex involvement Youichi MachidaAkiko ShimauchiEisuke Fukuma Original Article 20 February 2018 Pages: 456 - 463
Meta-analysis for psychological impact of breast reconstruction in patients with breast cancer Wanjing ChenXiaoai LvBei Wang Original Article 13 February 2018 Pages: 464 - 469
Diagnosis, characteristics, and treatment of breast carcinomas within benign fibroepithelial tumors Michiyo SaimuraKenichiro KogaSadafumi Tamiya Original Article 19 February 2018 Pages: 470 - 478
Cyclin-dependent kinase 4/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: a systematic review and meta-analysis of phase III randomized clinical trials Allan Ramos-EsquivelHellen Hernández-StellerDenis Ulises Landaverde Original Article 22 February 2018 Pages: 479 - 488
Effect of the normal mammary differentiation regulator ELF5 upon clinical outcomes of triple negative breast cancers patients Fumiya OmataKeely May McNamaraHironobu Sasano Rapid Communication 02 February 2018 Pages: 489 - 496